Additive effects of C2-ceramide on paclitaxel-induced premature senescence of human lung cancer cells

Jeff Yi Fu Chen, Chi Ching Hwang, Wei Yi Chen, Jing Ching Lee, Tzu Fun Fu, Kang Fang, Ying Chieh Chu, Ya Lan Huang, Jia Cheng Lin, Wen Hui Tsai, Hsueh Wei Chang, Bing Hung Chen, Chien Chih Chiu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aims: The aims of the study are to investigate the additive effect of exogenous short-carbon chain phospholipids, C2-ceramide, on an anti-cancer drug paclitaxel (PTX)-induced senescence of human non-small cell lung cancer (NSCLC) cells deficient in functional p53 and p16, and to examine whether mitogen-activated protein kinase (MAPK) plays a role in ceramide-sensitized senescence of NSCLC cells. Main methods: To determine whether exogenous C2-ceramide renders lung cancer cells more sensitive to PTX treatment, techniques employing a flow cytometry-based cell cycle analysis and acidic β-galactosidase staining for senescent cells were used. Furthermore, to elucidate the role of MAPK proteins in modulating senescence, assays for protein levels of selective MAPKs and Bcl-2 family members, and detection of transcriptional levels senescence-associated genes were used in the study. Key findings: A sub-lethal dose of C2-ceramide sensitized the NSCLC H1299 cells to PTX treatment. The additive effects of C2-ceramide and PTX resulted in proliferative inhibition, G2-phase arrest of cell cycle, activation of p38 and eventually premature senescence. Importantly, neither p53, p21waf1/cip1 nor p16ink4 was shown to be involved in C2-ceramide-sensitized proliferative inhibition and senescence of H1299 cells by PTX in our study. Significance: Our study demonstrates that the short-carbon chain C2-ceramide can effectively sensitize PTX-induced senescence of H1299 cells via both p21waf1/cip1- and p16ink4-independent pathways.

Original languageEnglish
Pages (from-to)350-357
Number of pages8
JournalLife Sciences
Volume87
Issue number11-12
DOIs
Publication statusPublished - 2010 Sep 1

Fingerprint

Paclitaxel
Lung Neoplasms
Cells
Non-Small Cell Lung Carcinoma
Cell Aging
Mitogen-Activated Protein Kinases
Carbon
Galactosidases
Flow cytometry
Ceramides
G2 Phase
Cell Cycle Checkpoints
N-acetylsphingosine
Assays
Phospholipids
Cell Cycle
Flow Cytometry
Proteins
Genes
Chemical activation

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Chen, J. Y. F., Hwang, C. C., Chen, W. Y., Lee, J. C., Fu, T. F., Fang, K., ... Chiu, C. C. (2010). Additive effects of C2-ceramide on paclitaxel-induced premature senescence of human lung cancer cells. Life Sciences, 87(11-12), 350-357. https://doi.org/10.1016/j.lfs.2010.06.017
Chen, Jeff Yi Fu ; Hwang, Chi Ching ; Chen, Wei Yi ; Lee, Jing Ching ; Fu, Tzu Fun ; Fang, Kang ; Chu, Ying Chieh ; Huang, Ya Lan ; Lin, Jia Cheng ; Tsai, Wen Hui ; Chang, Hsueh Wei ; Chen, Bing Hung ; Chiu, Chien Chih. / Additive effects of C2-ceramide on paclitaxel-induced premature senescence of human lung cancer cells. In: Life Sciences. 2010 ; Vol. 87, No. 11-12. pp. 350-357.
@article{adc26baa44154959b8f375636381ec0b,
title = "Additive effects of C2-ceramide on paclitaxel-induced premature senescence of human lung cancer cells",
abstract = "Aims: The aims of the study are to investigate the additive effect of exogenous short-carbon chain phospholipids, C2-ceramide, on an anti-cancer drug paclitaxel (PTX)-induced senescence of human non-small cell lung cancer (NSCLC) cells deficient in functional p53 and p16, and to examine whether mitogen-activated protein kinase (MAPK) plays a role in ceramide-sensitized senescence of NSCLC cells. Main methods: To determine whether exogenous C2-ceramide renders lung cancer cells more sensitive to PTX treatment, techniques employing a flow cytometry-based cell cycle analysis and acidic β-galactosidase staining for senescent cells were used. Furthermore, to elucidate the role of MAPK proteins in modulating senescence, assays for protein levels of selective MAPKs and Bcl-2 family members, and detection of transcriptional levels senescence-associated genes were used in the study. Key findings: A sub-lethal dose of C2-ceramide sensitized the NSCLC H1299 cells to PTX treatment. The additive effects of C2-ceramide and PTX resulted in proliferative inhibition, G2-phase arrest of cell cycle, activation of p38 and eventually premature senescence. Importantly, neither p53, p21waf1/cip1 nor p16ink4 was shown to be involved in C2-ceramide-sensitized proliferative inhibition and senescence of H1299 cells by PTX in our study. Significance: Our study demonstrates that the short-carbon chain C2-ceramide can effectively sensitize PTX-induced senescence of H1299 cells via both p21waf1/cip1- and p16ink4-independent pathways.",
author = "Chen, {Jeff Yi Fu} and Hwang, {Chi Ching} and Chen, {Wei Yi} and Lee, {Jing Ching} and Fu, {Tzu Fun} and Kang Fang and Chu, {Ying Chieh} and Huang, {Ya Lan} and Lin, {Jia Cheng} and Tsai, {Wen Hui} and Chang, {Hsueh Wei} and Chen, {Bing Hung} and Chiu, {Chien Chih}",
year = "2010",
month = "9",
day = "1",
doi = "10.1016/j.lfs.2010.06.017",
language = "English",
volume = "87",
pages = "350--357",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "11-12",

}

Chen, JYF, Hwang, CC, Chen, WY, Lee, JC, Fu, TF, Fang, K, Chu, YC, Huang, YL, Lin, JC, Tsai, WH, Chang, HW, Chen, BH & Chiu, CC 2010, 'Additive effects of C2-ceramide on paclitaxel-induced premature senescence of human lung cancer cells', Life Sciences, vol. 87, no. 11-12, pp. 350-357. https://doi.org/10.1016/j.lfs.2010.06.017

Additive effects of C2-ceramide on paclitaxel-induced premature senescence of human lung cancer cells. / Chen, Jeff Yi Fu; Hwang, Chi Ching; Chen, Wei Yi; Lee, Jing Ching; Fu, Tzu Fun; Fang, Kang; Chu, Ying Chieh; Huang, Ya Lan; Lin, Jia Cheng; Tsai, Wen Hui; Chang, Hsueh Wei; Chen, Bing Hung; Chiu, Chien Chih.

In: Life Sciences, Vol. 87, No. 11-12, 01.09.2010, p. 350-357.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Additive effects of C2-ceramide on paclitaxel-induced premature senescence of human lung cancer cells

AU - Chen, Jeff Yi Fu

AU - Hwang, Chi Ching

AU - Chen, Wei Yi

AU - Lee, Jing Ching

AU - Fu, Tzu Fun

AU - Fang, Kang

AU - Chu, Ying Chieh

AU - Huang, Ya Lan

AU - Lin, Jia Cheng

AU - Tsai, Wen Hui

AU - Chang, Hsueh Wei

AU - Chen, Bing Hung

AU - Chiu, Chien Chih

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Aims: The aims of the study are to investigate the additive effect of exogenous short-carbon chain phospholipids, C2-ceramide, on an anti-cancer drug paclitaxel (PTX)-induced senescence of human non-small cell lung cancer (NSCLC) cells deficient in functional p53 and p16, and to examine whether mitogen-activated protein kinase (MAPK) plays a role in ceramide-sensitized senescence of NSCLC cells. Main methods: To determine whether exogenous C2-ceramide renders lung cancer cells more sensitive to PTX treatment, techniques employing a flow cytometry-based cell cycle analysis and acidic β-galactosidase staining for senescent cells were used. Furthermore, to elucidate the role of MAPK proteins in modulating senescence, assays for protein levels of selective MAPKs and Bcl-2 family members, and detection of transcriptional levels senescence-associated genes were used in the study. Key findings: A sub-lethal dose of C2-ceramide sensitized the NSCLC H1299 cells to PTX treatment. The additive effects of C2-ceramide and PTX resulted in proliferative inhibition, G2-phase arrest of cell cycle, activation of p38 and eventually premature senescence. Importantly, neither p53, p21waf1/cip1 nor p16ink4 was shown to be involved in C2-ceramide-sensitized proliferative inhibition and senescence of H1299 cells by PTX in our study. Significance: Our study demonstrates that the short-carbon chain C2-ceramide can effectively sensitize PTX-induced senescence of H1299 cells via both p21waf1/cip1- and p16ink4-independent pathways.

AB - Aims: The aims of the study are to investigate the additive effect of exogenous short-carbon chain phospholipids, C2-ceramide, on an anti-cancer drug paclitaxel (PTX)-induced senescence of human non-small cell lung cancer (NSCLC) cells deficient in functional p53 and p16, and to examine whether mitogen-activated protein kinase (MAPK) plays a role in ceramide-sensitized senescence of NSCLC cells. Main methods: To determine whether exogenous C2-ceramide renders lung cancer cells more sensitive to PTX treatment, techniques employing a flow cytometry-based cell cycle analysis and acidic β-galactosidase staining for senescent cells were used. Furthermore, to elucidate the role of MAPK proteins in modulating senescence, assays for protein levels of selective MAPKs and Bcl-2 family members, and detection of transcriptional levels senescence-associated genes were used in the study. Key findings: A sub-lethal dose of C2-ceramide sensitized the NSCLC H1299 cells to PTX treatment. The additive effects of C2-ceramide and PTX resulted in proliferative inhibition, G2-phase arrest of cell cycle, activation of p38 and eventually premature senescence. Importantly, neither p53, p21waf1/cip1 nor p16ink4 was shown to be involved in C2-ceramide-sensitized proliferative inhibition and senescence of H1299 cells by PTX in our study. Significance: Our study demonstrates that the short-carbon chain C2-ceramide can effectively sensitize PTX-induced senescence of H1299 cells via both p21waf1/cip1- and p16ink4-independent pathways.

UR - http://www.scopus.com/inward/record.url?scp=77956414743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956414743&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2010.06.017

DO - 10.1016/j.lfs.2010.06.017

M3 - Article

C2 - 20624405

AN - SCOPUS:77956414743

VL - 87

SP - 350

EP - 357

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 11-12

ER -